TG Therapeutics
TGTX
#3351
Rank
NZ$7.46 B
Marketcap
NZ$47.03
Share price
-1.53%
Change (1 day)
-14.45%
Change (1 year)

Earnings for TG Therapeutics (TGTX)

Earnings in 2025 (TTM): NZ$0.19 Billion

According to TG Therapeutics's latest financial reports the company's current earnings are NZ$0.53 Billion. In 2024 the company made an earning of NZ$82.43 Million, an increase over its 2023 earnings that were of NZ$42.54 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for TG Therapeutics from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.19 B139.31%
2024 NZ$82.43 M93.76%
2023 NZ$42.54 M-113.65%
2022 -NZ$0.32 Billion-45.06%
2021 -NZ$0.57 Billion25.42%
2020 -NZ$0.46 Billion62.93%
2019 -NZ$0.28 Billion-3.34%
2018 -NZ$0.29 Billion46.05%
2017 -NZ$0.2 Billion48.38%
2016 -NZ$0.14 Billion29.09%
2015 -NZ$0.11 Billion12.99%
2014 -NZ$90.89 Million180.92%
2013 -NZ$32.36 Million
2009 -NZ$2.94 Million-59.85%
2008 -NZ$7.32 Million
2006 -NZ$16.58 Million-48.34%
2005 -NZ$32.08 Million215.12%
2004 -NZ$10.18 Million29.1%
2003 -NZ$7.89 Million159.59%
2002 -NZ$3.04 Million
2000 -NZ$5.22 Million12.38%
1999 -NZ$4.64 Million7.69%
1998 -NZ$4.31 Million-49.02%
1997 -NZ$8.46 Million82.14%
1996 -NZ$4.64 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Alkermes
ALKS
NZ$0.67 B 252.69%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Dr. Reddy's Laboratories
RDY
NZ$1.44 B 659.41%๐Ÿ‡ฎ๐Ÿ‡ณ India